Article
A routinely used protein staining dye acts as an inhibitor of wild type and mutant alpha-synuclein aggregation and modulator of neurotoxicity.
European journal of medicinal chemistry - 1 Jan 2018
Ahsan Nuzhat, Siddique Ibrar Ahmed, Gupta Sarika, Surolia Avadhesha
Abstract excerpt
Inhibition of amyloid formation along with modulation of toxicity employing small molecules is emerging as a potential therapeutic approach for protein misfolding disorders which includes Parkinson's disease, Alzheimer's disease and Multiple System Atrophy etc. Countless current interventional strategies for treating α-synucleinopathies consider using peptidic and non-peptidic inhibitors for arresting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
